Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

被引:1
|
作者
Crazzolara, Roman [1 ]
Kropshofer, Gabriele [1 ]
Steurer, Michael [2 ]
Sopper, Sieghart [2 ,3 ]
Schwinger, Wolfgang [4 ]
机构
[1] Med Univ Innsbruck, Dept Pediat, Innsbruck, Austria
[2] Med Univ Innsbruck, Dept Internal Med Hematol & Oncol 5, Innsbruck, Austria
[3] Tyrolean Canc Res Inst, Innsbruck, Austria
[4] Med Univ Graz, Dept Pediat, Graz, Austria
来源
关键词
Developmental Biology; Issue; 127; Mixed chimerism; split chimerism; hemoglobinopathies; hematopoietic stem cell transplantation; colony forming units; flow cytometry; sorting; DNA (STR) analysis; BONE-MARROW-TRANSPLANTATION; BETA-THALASSEMIA MAJOR; MIXED CHIMERISM; LONG-TERM; MANAGEMENT; DISEASE;
D O I
10.3791/56002
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The presence of incomplete chimerism is noted in a large proportion of patients following bone marrow transplant for thalassemia major or sickle cell disease. This observation has tremendous implications, as subsequent therapeutic immunomodulation strategies can improve clinical outcome. Conventionally, polymerase chain reaction-based analysis of short tandem repeats is used to identify chimerism in donor-derived blood cells. However, this method is restricted to nucleated cells and cannot distinguish between dissociated single-cell lineages. We applied the analysis of short tandem repeats to flow cytometric-sorted hematopoietic progenitor cells and compared this with the analysis of short tandem repeats obtained from selected burst-forming unit - erythroid colonies, both collected from the bone marrow. With this method we are able to demonstrate the different proliferation and differentiation of donor cells in the erythroid compartment. This technique is eligible to complete current monitoring of chimerism in the stem cell transplant setting and thus may be applied in future clinical studies, stem cell research and design of gene therapy trials.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver
    Wang, Xiao Qi
    Lo, Chung Mau
    Chen, Lin
    Cheung, Cindy K. Y.
    Fan, Sheung Tat
    [J]. CANCER RESEARCH, 2012, 72
  • [42] Persistence of severe aplastic anemia in donor type cells after unrelated hematopoietic stem cell transplantation
    Staehelin, F
    Avoledo, P
    Passweg, J
    Tichelli, A
    Gratwohl, A
    Kühne, T
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S263 - S263
  • [43] Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma
    Havelange, V.
    Antoine-Poirel, H.
    Saussoy, P.
    Van Den Neste, E.
    Ferrant, A.
    [J]. ACTA CLINICA BELGICA, 2006, 61 (02): : 82 - 86
  • [44] Prognostic significance of minimal residual disease after hematopoietic stem cell transplantation
    Gruhn, B
    Häfer, R
    Voigt, A
    Wittig, S
    Fuchs, D
    Hermann, J
    Zintl, F
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S124 - S124
  • [45] The Effect of Donor Age on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Ali, Maryan
    Grenvold, Bjorn Christer
    Tjonnfjord, Geir Erland
    Mattsson, Jonas
    Lundin, Katrin Ulrike
    Myhre, Anders Eivind
    Abrahamsen, Ingerid Weum
    Gedde-dahl, Tobias
    Floisand, Yngvar
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S282 - S282
  • [46] Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation
    Yegin, Zeynep Arzu
    Ozkurt, Zuebeyde Nur
    Aki, Sahika Zeynep
    Sucak, Guelsan Tuerkoez
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2010, 42 (03) : 239 - 245
  • [47] Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation
    Tan, Yamin
    Du, Kaili
    Luo, Yi
    Shi, Jimin
    Cao, Ling
    Zheng, Yanlong
    Zheng, Gaofeng
    Zhao, Yanmin
    Ye, Xiujing
    Cai, Zhen
    Huang, He
    [J]. TRANSFUSION, 2014, 54 (06) : 1493 - 1500
  • [48] Donor-Derived Solid Malignancies after Hematopoietic Stem Cell Transplantation
    Hu, Yong-xian
    Cui, Qu
    Liang, Bin
    Huang, He
    [J]. ONKOLOGIE, 2010, 33 (04): : 195 - 200
  • [49] Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells
    Leung, Cindy G.
    Xu, Yanfei
    Mularski, Bretton
    Liu, Hui
    Gurbuxani, Sandeep
    Crispino, John D.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (07): : 1603 - 1611
  • [50] Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells
    Kharbanda, Sandhya
    Smith, Angela R.
    Hutchinson, Stephanie K.
    McKenna, David H.
    Ball, James B.
    Lamb, Lawrence S., Jr.
    Agarwal, Rajni
    Weinberg, Kenneth I.
    Wagner, John E., Jr.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) : 581 - 586